Bryan Lawlis V

Insider Reports History

Signature
/s/ Scott A. Samuels, Attorney-in-fact for V. Bryan Lawlis
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bryan Lawlis V:

Form 4 holding Director

GERON CORP

Security class
Stock Option (right to buy)
Shares / value
180,000
Estimated value
Report date
21 May 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Aeglea BioTherapeutics, Inc.

Security class
Director Stock Option (right to buy)
Shares / value
43,000
Estimated value
Report date
07 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Bryan Lawlis V

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .